Pacific Biosciences Q2 Adj. EPS $(0.13) Beats $(0.17) Estimate, Sales $39.766M Beat $36.886M Estimate

Benzinga08-08

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.98 percent. This is a 35 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $39.766 million which beat the analyst consensus estimate of $36.886 million by 7.81 percent. This is a 10.42 percent increase over sales of $36.013 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法